Sophie Merckelbach1,2, Emiel P C van der Vorst3, Michael Kallmayer1, Christoph Rischpler4, Rainer Burgkart5, Yvonne Döring3, Gert-Jan de Borst2, Markus Schwaiger4, Hans-Henning Eckstein1,6, Christian Weber3,6, Jaroslav Pelisek1,6. 1. Department of Vascular and Endovascular Surgery, Technische Universität München, München, Germany. 2. Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands. 3. Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität München, München, Germany. 4. Department of Nuclear Medicine, Technische Universität München, München, Germany. 5. Clinic of Orthopedics, Technische Universität München, München, Germany. 6. DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Abstract
BACKGROUND AND AIMS: The CXCR4/CXCL12 complex has already been associated with progression of atherosclerosis; however, its exact role is yet unknown. The aim of this study was to analyse the expression and cellular localization of CXCL12 and its receptor CXCR4 in human carotid atherosclerotic plaques. METHODS: Carotid plaques (n = 58; 31 stable, 27 unstable, based on histological characterization of plaque morphology) were obtained during carotid endarterectomy, and 10 healthy vessels were used as a control. Expression of cxcr4, cxcr7, cxcl12, ccl2/ccr2 and csf1/csf1r was analysed at mRNA, and level expression of CXCR4, CXCR7 and CXCL12 was analysed at protein level. Cellular localization was determined using consecutive and double immunohistochemical (IHC) staining and microdissection. RESULTS: At mRNA level, cxcr4, cxcr7 and cxcl12 were significantly higher expressed in stable carotid plaques compared with controls (p = 0.011, p < 0.001 and p < 0.001). Cxcl12 mRNA expression was successively augmented toward unstable plaques (p < 0.001). At protein level, CXCR4, CXCR7 and CXCL12 expression was significantly increased in both stable (p = 0.001, p < 0.001 and p = 0.035, respectively) and unstable (p = 0.003, p < 0.001 and p = 0.045, respectively) plaques compared with controls. Using IHC, CXCR4 was particularly localized in macrophages and small neovessels. Microdissection confirmed strongest expression of cxcr4 in macrophages within atherosclerotic plaques. Leukocytes and smooth muscle cells showed cxcr4 expression as well. For cxcl12, only microdissected areas with macrophages were positive. CONCLUSION: Expression of CXCR4 and CXCL12 was significantly increased in both stable and unstable carotid atherosclerotic plaques compared with healthy vessels, both at mRNA and protein level. CXCR4 and CXCL12 were localized particularly in macrophages. Schattauer GmbH Stuttgart.
BACKGROUND AND AIMS: The CXCR4/CXCL12 complex has already been associated with progression of atherosclerosis; however, its exact role is yet unknown. The aim of this study was to analyse the expression and cellular localization of CXCL12 and its receptor CXCR4 in human carotid atherosclerotic plaques. METHODS: Carotid plaques (n = 58; 31 stable, 27 unstable, based on histological characterization of plaque morphology) were obtained during carotid endarterectomy, and 10 healthy vessels were used as a control. Expression of cxcr4, cxcr7, cxcl12, ccl2/ccr2 and csf1/csf1r was analysed at mRNA, and level expression of CXCR4, CXCR7 and CXCL12 was analysed at protein level. Cellular localization was determined using consecutive and double immunohistochemical (IHC) staining and microdissection. RESULTS: At mRNA level, cxcr4, cxcr7 and cxcl12 were significantly higher expressed in stable carotid plaques compared with controls (p = 0.011, p < 0.001 and p < 0.001). Cxcl12 mRNA expression was successively augmented toward unstable plaques (p < 0.001). At protein level, CXCR4, CXCR7 and CXCL12 expression was significantly increased in both stable (p = 0.001, p < 0.001 and p = 0.035, respectively) and unstable (p = 0.003, p < 0.001 and p = 0.045, respectively) plaques compared with controls. Using IHC, CXCR4 was particularly localized in macrophages and small neovessels. Microdissection confirmed strongest expression of cxcr4 in macrophages within atherosclerotic plaques. Leukocytes and smooth muscle cells showed cxcr4 expression as well. For cxcl12, only microdissected areas with macrophages were positive. CONCLUSION: Expression of CXCR4 and CXCL12 was significantly increased in both stable and unstable carotid atherosclerotic plaques compared with healthy vessels, both at mRNA and protein level. CXCR4 and CXCL12 were localized particularly in macrophages. Schattauer GmbH Stuttgart.
Authors: Emiel P C van der Vorst; Linsey J F Peters; Madeleine Müller; Selin Gencer; Yi Yan; Christian Weber; Yvonne Döring Journal: Front Pharmacol Date: 2019-05-22 Impact factor: 5.810
Authors: Xiang Li; Wei Yu; Tim Wollenweber; Xia Lu; Yongxiang Wei; Dietrich Beitzke; Wolfgang Wadsak; Saskia Kropf; Hans J Wester; Alexander R Haug; Xiaoli Zhang; Marcus Hacker Journal: Eur J Nucl Med Mol Imaging Date: 2019-04-19 Impact factor: 9.236
Authors: María Marcos-Jubilar; Josune Orbe; Carmen Roncal; Florencio J D Machado; José Antonio Rodriguez; Alejandro Fernández-Montero; Inmaculada Colina; Raquel Rodil; Juan C Pastrana; José A Páramo Journal: Life (Basel) Date: 2021-05-01
Authors: Thorsten Derlin; Daniel G Sedding; Jochen Dutzmann; Arash Haghikia; Tobias König; L Christian Napp; Christian Schütze; Nicole Owsianski-Hille; Hans-Jürgen Wester; Saskia Kropf; James T Thackeray; Jens P Bankstahl; Lilli Geworski; Tobias L Ross; Johann Bauersachs; Frank M Bengel Journal: Eur J Nucl Med Mol Imaging Date: 2018-07-03 Impact factor: 9.236